Verastem Oncology
VSTM
$2.94
Share price
-5.16%
Change (1 day)
-65.61%
Change (1 year)
Categories
Market capitalization of Verastem Oncology (VSTM)
Market cap: $74.45 Million
As of June 2024 Verastem Oncology has a market cap of $74.45 Million. This makes Verastem Oncology the world's 7651th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Verastem Oncology from 2012 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $74.45 M | -63.8% |
| 2023 | $0.20 B | 143.23% |
| 2022 | $84.56 M | -77.36% |
| 2021 | $0.37 B | 3.28% |
| 2020 | $0.36 B | 236.83% |
| 2019 | $0.10 B | -56.71% |
| 2018 | $0.24 B | 59.84% |
| 2017 | $0.15 B | 274.47% |
| 2016 | $41.43 M | -39.7% |
| 2015 | $68.71 M | -72.42% |
| 2014 | $0.24 B | -13.71% |
| 2013 | $0.28 B | 61.31% |
| 2012 | $0.17 B |
End of Day market cap according to different sources
On Jun 25th, 2024 the market cap of Verastem Oncology was reported to be:
$74.45 Million
$74.45 Million
$74.45 Million
$74.45 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $158.60 B | 212,918.64% | 🇺🇸 USA |
 LabCorp LH | $17.51 B | 23,429.71% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $82.89 B | 111,229.75% | 🇬🇧 UK |
 Curis CRIS | $46.2 M | -37.94% | 🇺🇸 USA |